iiinova — where your digital self keeps evolving

Alliance for Cancer Gene Therapy @acgtfoundation.bsky.social · 07/07/2026

Cell therapy has transformed blood cancers, but these treatments have had much less success against solid tumors like sarcoma. Fortunately, the tide has begun to turn, as Dr. Stephen Gottschalk of @stjuderesearch.bsky.social explains. acgtfoundation.org/acgt-blog/sa...

acgtfoundation.org

Solving Sarcoma with Dr. Stephen Gottschalk

For Sarcoma Awareness Month, we spoke with Dr. Stephen Gottschalk to learn about the latest clinical advances for these rare cancers.

010

Alliance for Cancer Gene Therapy @acgtfoundation.bsky.social · 25/06/2026

This month, the Alliance for Cancer Gene Therapy proudly welcomed Jonathan S. Doctor and John Neamonitis to our Board of Directors! acgtfoundation.org/acgt-blog/jo...

acgtfoundation.org

ACGT Adds Two New Members to Board of Directors

Both Doctor and Neamonitis have extensive experience building and guiding successful enterprises.

000

Alliance for Cancer Gene Therapy @acgtfoundation.bsky.social · 18/06/2026

ASCO 2026 delivered real hope for some of the hardest-to-treat cancers. A KRAS-targeting therapy nearly doubled survival in metastatic pancreatic cancer, while personalized vaccines and CAR T cells showed progress in glioblastoma. Read our full recap here! acgtfoundation.org/acgt-blog/as...

acgtfoundation.org

ASCO 2026: Advances in Pancreatic Cancer, Glioblastoma, and More

ASCO 2026 revealed promising advances in hard-to-treat pancreatic and brain cancers, including with CAR T cells and personalized vaccine therapies.

000

Reposted by Alliance for Cancer Gene Therapy

Michael Lin, MD PhD @michaelzlin.bsky.social · 17/06/2026

Today I’m excited to share our new study in Nature Biomedical Engineering, in which we used protein engineering to create a therapeutic able to completely eradicate metastatic ovarian cancer in mice. 🧵 www.nature.com/articles/s41...

nature.com

Rewiring oncogenic signalling to precision ablation of metastatic cancer - Nature Biomedical Engineering

An engineered ErbB oncogene-selective virus shows improved safety and efficacy for treating mouse models of ErbBr/HER2 positive ovarian cancer, showing promise for curing early cases and substantially...

1318

Alliance for Cancer Gene Therapy @acgtfoundation.bsky.social · 16/06/2026

During our 25th anniversary, ACGT Summit 2026 brought together the field's leading minds to debate the future of cancer cell and gene therapy. Read our recap on the breakthroughs, barriers, and bold strategies shaping what comes next. acgtfoundation.org/acgt-blog/su...

acgtfoundation.org

ACGT Summit 2026: 25 Years of Cell and Gene Therapy

Twenty-five years of cancer cell and gene therapy, and navigating the road ahead, at ACGT Summit 2026

030